HSCS (HeartSciences) Other Current Liabilities: $0.09 Mil (As of Jan. 2026)


HSCS HeartSciences Inc HSCS
42 GF Score
Price $2.81
GF Value $2.60
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Other Current Liabilities?

HeartSciences HSCS -4.78% 42 Other Current Liabilities is $0.09 Mil as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 42/100 and a GF Value™ of $2.60 (Fairly Valued). The stock has 7 warning signs investors should review.

HeartSciences's other current liabilities for the quarter that ended in Jan. 2026 was $0.09 Mil.

HeartSciences's quarterly other current liabilities declined from Jul. 2025 ($0.22 Mil) to Oct. 2025 ($0.15 Mil) and declined from Oct. 2025 ($0.15 Mil) to Jan. 2026 ($0.09 Mil).

HeartSciences's annual other current liabilities declined from Apr. 2023 ($0.05 Mil) to Apr. 2024 ($0.03 Mil) and declined from Apr. 2024 ($0.03 Mil) to Apr. 2025 ($0.03 Mil).

HeartSciences Other Current Liabilities Related Terms

HeartSciences Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for HeartSciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Other Current Liabilities Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Other Current Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.05 0.03 0.03

HeartSciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.03 0.22 0.15 0.09
HSCS
42GF Score
HeartSciences Inc HSCS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.09 Mil mean?
HeartSciences (HSCS) has a Other Current Liabilities of $0.09 Mil as of Jan. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on HeartSciences.
Is HeartSciences' Other Current Liabilities too high?
HeartSciences' current Other Current Liabilities is $0.09 Mil. Overall, HeartSciences has a GF Score™ of 42/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Other Current Liabilities compare to CSDX and CODX?
HeartSciences' Other Current Liabilities of $0.09 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on HeartSciences. HeartSciences's current Other Current Liabilities is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Fairly Valued. The stock's GF Value™ is $2.60, compared to a current price of $2.81 — trading 8.1% above its estimated fair value. The current Other Current Liabilities is $0.09 Mil. HeartSciences' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For HeartSciences (HSCS), the current Other Current Liabilities is $0.09 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.81 is trading 8.1% above its estimated GF Value™ of $2.60. GuruFocus considers HeartSciences to be Fairly Valued.

Key valuation signals for HSCS:

  • Other Current Liabilities: $0.09 Mil
  • GF Value™: $2.60 vs. price of $2.81 (8.1% above fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
42GF Score

Get the complete analysis for HSCS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.81
Price
$2.60
GF Value